A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a Next-Generation Propellant in Participants 40 to 80 Years of Age With COPD

Clinical trial NCT06075095 · COMPLETED

Trial details

NCT number: NCT06075095
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

COPD (Chronic Obstructive Pulmonary Disease)

Start date: 2024-01-11
Primary completion: 2025-08-12
Enrollment: 297

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.